Last reviewed · How we verify
Crampol (acetylpheneturide)
Crampol (generic name: acetylpheneturide) is a drug. It is currently in unknown development for Epilepsy.
Crampol works by modulating neuronal activity to reduce seizure frequency.
Crampol (acetylpheneturide) is a small molecule modality developed for the treatment of epilepsy. Its exact mechanism of action and target are unknown, but it is believed to work by modulating neuronal activity. Crampol is used to manage seizures in patients with epilepsy, but its commercial status and safety considerations are not well-documented. Further research is needed to fully understand its pharmacological properties and potential risks. As a result, its use should be approached with caution and under the guidance of a qualified healthcare professional.
At a glance
| Generic name | acetylpheneturide |
|---|---|
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your brain is a busy city with many different neighborhoods. Crampol helps calm down the activity in the neighborhoods where seizures occur, making it less likely for them to happen. This is done by affecting the way neurons communicate with each other.
Approved indications
- Epilepsy
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Crampol CI brief — competitive landscape report
- Crampol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Crampol
What is Crampol?
How does Crampol work?
What is Crampol used for?
What is the generic name of Crampol?
What development phase is Crampol in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Indication: Drugs for Epilepsy
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing